Compare Bio Protocol (BIO) vs Newton Protocol (NEWT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Newton Protocol — how do they compare? Bio Protocol trades at Rp428.05 (market cap Rp972,61M, Rp151,33M 24h volume), while Newton Protocol trades at Rp653.71 (market cap Rp204,66M, Rp39,06M 24h volume). The key difference: Bio Protocol is far larger — about 4.8× Newton Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 312,8M / 1B NEWT (32%) for Newton Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Newton Protocol for 26 Days on average.
| BIO | NEWT | |
|---|---|---|
Market Cap | Rp972,61M | Rp204,66M |
Volume (24h) | Rp151,33M | Rp39,06M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 312,8M / 1B NEWT (32%) |
Typical Hold Time | 18 Days | 26 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Newton Protocol (NEWT) is currently trading at Rp672.2 with a market cap of Rp210.53M, showing bearish technical signals despite oversold RSI conditions. The token faces selling pressure with moving averages indicating a downtrend, though oscillators suggest potential near-term recovery. With only 32% of the 1M max supply in circulation and an average hold time of 26 days, the token shows moderate network participation. Recent ecosystem developments focus on protocol integrations and payment system enhancements.
Overall outlook remains cautious with technical weakness but potential for oversold bounce. Key opportunities include the low circulating supply creating scarcity potential, while major risks involve the bearish trend continuation and limited liquidity. Investors should monitor support at Rp650 and resistance at Rp682 for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Newton Protocol
The Newton Protocol serves as a verifiable automation layer for on-chain finance, enabling users to delegate complex, cross-chain actions to AI agents while ensuring that each step adheres to user-DeFined guidelines through cryptographic guarantees. It combines smart accounts, such as ERC-4337 and EIP-7702, to allow for detailed delegation, along with trusted execution environment (TEE) attestations and zero-knowledge proofs (ZKPs) to verify the correctness of every off-chain decision. The ultimate aim is to transform automation into a trust-minimized framework, thereby facilitating agentic finance across multiple blockchains.
Read more on NEWT →
